Efficacy and Safety of Adalimumab as Monotherapy Versus Adalimumab With Methotrexate for Psoriasis: A Systematic Review
Cureus · 17.03.2026
DOI: 10.7759/cureus.105411 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 17.03.2026. Verfasst von Ahmed F Alanazi und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU.
- Faculty of Medicine, Jazan University, Jazan, SAU.
- College of Medicine, Taif University, Taif, SAU.
- Department of Dermatology, King Salman Hospital, Riyadh, SAU.
Zitieren
APA
Alanazi, A. F., Almahdi, M. A., Alqurashi, S. O., Alassaf, S., Almohanna, A., Alayed, S. T., Alshehri, M., Alsubaie, K. S., & Hakami, S. (2026). Efficacy and Safety of Adalimumab as Monotherapy Versus Adalimumab With Methotrexate for Psoriasis: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.105411
Vancouver
Alanazi AF, Almahdi MA, Alqurashi SO, Alassaf S, Almohanna A, Alayed ST, et al. Efficacy and Safety of Adalimumab as Monotherapy Versus Adalimumab With Methotrexate for Psoriasis: A Systematic Review. Cureus. 2026. doi:10.7759/cureus.105411
BibTeX
@article{Alanazi2026,
author = {Alanazi, Ahmed F and Almahdi, Muhammad A and Alqurashi, Shaden O and Alassaf, Saud and Almohanna, Abdulaziz and Alayed, Salman T and Alshehri, Mohammed and Alsubaie, Kadi S and Hakami, Salha},
title = {Efficacy and Safety of Adalimumab as Monotherapy Versus Adalimumab With Methotrexate for Psoriasis: A Systematic Review},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.105411}
}
EUVIMED